Bio-Rad Laboratories QX ONE Droplet Digital PCR System DdPCR for Quantitative Nucleic Acid
Bio-Rad Laboratories
Details
-
CategoryMolecular Biology
-
Dimension26.0in x 49.0in x 30.0in
-
Serial766BR2293
-
Shipping TypeFedEx Ground
-
Manufacturing2025-08-01
-
Voltage / Hertz100-240 vac
Description
Bio-Rad Laboratories QX ONE droplet digital PCR system, manufactured 2025-08 (Serial 766BR2293). This DdPCR instrument partitions PCR reactions into thousands of droplets to enable quantitative nucleic acid amplification for molecular biology workflows. The unit is in E (Excellent) condition, described as near-new with minimal prior use, and its working status is based on the intake inspection. Electrical specifications include 100-240 VAC input and 50/60 Hz operation, with label-referenced current of 10A-4.6A. FCC Part 15 compliance is indicated on the equipment label (label also references 2012/19/EU WEEE). Ideal for labs running ddPCR assays for sensitive quantification of DNA or RNA targets.
Key Features
- Droplet digital PCR partitioning to divide PCR reactions into thousands of droplets
- Quantitative nucleic acid amplification for DNA or RNA targets
Specifications
- Voltage: 100-240 vac
- Frequency: 50/60 hz
- Current: 10a-4.6a
- Country of Origin: United States
- Manufacture Date: 2025-08
- Serial Number: 766BR2293
- Certifications: FCC Part 15 compliance (as stated on label)
- Standards: FCC rules Part 15 (label also references 2012/19/EU WEEE)
Weight
Imperial: 264.0 Pounds
Metric: 119.75 Kilograms
Shipping Dimensions
Imperial: 31.2 in x 58.8 in x 36.0 in
Metric: 79.25 cm x 149.35 cm x 91.44 cm
Product Enquiry
Have a question about this product? Send us your enquiry and our sales team will get back to you shortly.
Inform me when available
This item has sold. Leave your details and we will get in touch when a similar model becomes available.
Product Make Offer
Submit your best offer for this product. Our sales team will review your request and connect with you as soon as possible.
Comments 0
There are currently no public comments.